Sustained oral mucosal delivery in human volunteers of buprenorphine from a thin non-eroding mucoadhesive polymeric disk
- 30 June 1995
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 34 (3) , 243-250
- https://doi.org/10.1016/0168-3659(95)00008-v
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Clinical pharmacology of buprenorphine: Ceiling effects at high dosesClinical Pharmacology & Therapeutics, 1994
- Bioadhesive Polymer Buccal Patches for Buprenorphine Controlled Delivery: Formulation, In-vitro Adhesion and Release PropertiesDrug Development and Industrial Pharmacy, 1994
- Opioid Agonist-Antagonist Drugs in Acute and Chronic Pain StatesDrugs, 1991
- Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose inductionClinical Pharmacology & Therapeutics, 1989
- “PATIENT DEMAND” POSTOPERATIVE ANALGESIA WITH BUPRENORPHINEBritish Journal of Anaesthesia, 1986
- Buprenorphine as new treatment for heroin dependenceDrug and Alcohol Dependence, 1985
- Relationship of Morphine-Induced Miosis to Plasma Concentration in Normal SubjectsJournal of Pharmaceutical Sciences, 1984
- Clinical Pharmacokinetics of Narcotic Agonist-Antagonist DrugsClinical Pharmacokinetics, 1983
- Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis.British Journal of Clinical Pharmacology, 1982
- SINGLE-DOSE COMPARISON OF BUPRENORPHINE 0.3 AND 0.6 MG I.V. GIVEN AFTER OPERATION: CLINICAL EFFECTS AND PLASMA CONCENTRATIONSBritish Journal of Anaesthesia, 1982